Study on the Expression of the Human Novel Gene NM23-H1B in Epithelial Ovarian Cancer

李文,刘彦,金志军,丰有吉,徐玲玲,侯庆香
DOI: https://doi.org/10.3969/j.issn.0253-9934.2004.09.006
2004-01-01
Abstract:Objective To study the expression of the novel human gene NM23-H1B in ovarian cancer.Methods 24 specimans from patients with epithelial ovarian tumor at different clinical stages and 4 from normal ovaries were examined for NM23-H1B mRNA expression by using RT-PCR and Northern blot.Results All specimans expressed NM23-H1B mRNA through RT-PCR, while the level of expression in ovarian cancer was higher than that from the normal ovary. The results of Northern hybridization showed that NM23-H1B was overexpressed in ovarian cancer but less expressed in normal ovary or in those with LMP(low malignant potential). The levels of expression in early stages(stageⅠand Ⅱ) cancer were higher than those of advanced (stage Ⅲ and Ⅳ) cancers.In early stage carcinoma, the expression levels were related with the differentiation of tumor cells. Well-differentiated cancer expressed NM23-H1B mRNA in comparatively higher level.Conclusion The novel gene NM23-N1B is related with ovarian cancer significantly.
What problem does this paper attempt to address?